BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 8, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for March 20, 2026

March 20, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: AC Immune, AL-S Pharma, C2N, Causeway, Clearmind, Kelun-Biotech, Pfizer, Totus, Vaxcyte.
Read More

In the clinic for March 19, 2026

March 19, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Aspen, Arvinas, Beyond Cancer, Biovica, Freenome, Gain, Okyo, Ovid, Sobi.
Read More

In the clinic for March 18, 2026

March 18, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Acumen, Aro, Ascendis, Ataibeckley, Candel, Cognition, Endogenex, Eupraxia, Greenwich, Heartflow, Mdxhealth, Neurosense, Pfizer, Priavoid, Rhythm.
Read More

In the clinic for March 17, 2026

March 17, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Alessa, Almirall, Bayer, Biomarin, Biomea, Cytomx, Eledon, Eli Lilly, J&J, Nasus, Relay, Sarepta, Structure.
Read More

In the clinic for March 17, 2026

March 17, 2026
Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Ascletis, Immutep, Otsuka, Telix.
Read More

In the clinic for March 16, 2026

March 16, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Beren, Immutep, Insight Molecular, Sana, Ultragenyx.
Read More

In the clinic for March 13, 2026

March 13, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Bridgebio, Capricor, Insulet, Intensity, Noah, Otsuka, Personalis, Prelude, Regenxbio, Solid, United.
Read More

In the clinic for March 12, 2026

March 12, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Biogen, Genethon, Lexicon, UCB.
Read More

In the clinic for March 11, 2026

March 11, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Aptevo, Arcutis, Ascletis, Celcuity, Citius, Edgewise, Excellthera, Kainova, Neurosense, NMD, SAB, Satellos, Telix, Tonix, Vertex.
Read More

In the clinic for March 10, 2026

March 10, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Atamyo, Benitec, Biofrontera, BMS, Bonesupport, Castle, Crestone, Dianthus, Dyne, Ipsen, ITF, Keros, Novabridge, Novelmed, Numares, Pfizer, Pulse, Regeneron, Relmada, Roche, Santhera, Spyglass, TG, Tris, Visara, Xenon.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 323 324 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 7, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing